Ann: MedAdvisor Quarterly Update and Appendix 4C, page-7

ALC, 1ST, PCK, RAP all bagging over the last month or two.

I suspect there’s more free float with these registers for retail/sophs to push around.

I also assume these coys may still be operating at a loss so need a healthy cash balance or access to cash.

Still ~$6M left in cash after EBOS tipped in ~$10M in October 2017.

International integration and regulatory compliance is now complete.

The numbers here show less outgoings than the previous quarter.

I like MDR over those tickers because of the tight register, reduction in outgoings and large cash balance and not to mention a presence on three continents AU, US and Asia.

And potentially four with approval to integrate with NHS systems in the UK.

Perhaps we will bag from 5.5c instead of $0.04?